Coronil comes as a shot in the arm for Ramdev’s Patanjali
The herbal concoction isn’t really a defence against COVID-19 but its immense popularity may just be the panacea that a flailing Patanjali is looking for.
We rarely make our stories free to read. This one is, so make the most of it.
We publish over 500 original, detailed stories every year on startups, corporates, stock markets and economic current affairs.
No payment details required
$99 for one year
More in Business
You may also like
Why is Reliance taking Campa Cola to the Middle East?
The region’s growing demand for carbonated beverages and the presence of a large Indian diaspora present an opportunity for the Mukesh Ambani-led conglomerate to up its FMCG game through the iconic brand.
How Bewakoof, once a trendsetter, fell out of favour with young people
Indian youngsters are experimenting with newer D2C brands like never before. Bewakoof’s early success and its 2022 acquisition by retail giant Aditya Birla Fashion should have given it the edge, but the company has been left behind.
Gen Z is driving India’s consumption and spending habits
Even as they change consumer preferences to more sustainable, healthy and premium products, this young generation is also fueling the overall spend in products ranging from skincare to cars.